Abstract
This chapter will focus on two genetic syndromes affecting gonadotropin function that typically present in childhood, Klinefelter syndrome, and testotoxicosis.
Klinefelter syndrome (47,XXY) is the most common sex chromosome aneuploidy with a prevalence of 1 in 450–500 male births. Unless detected by prenatal screening or prenatal diagnosis, this chromosome variation diagnosis is frequently missed in children. Physical, neurocognitive, and psychosocial phenotypes of boys with 47,XXY are extremely variable, making a typical case difficult to characterize. Health care needs of boys born with 47,XXY are complex including the need for monitoring growth, pubertal development, optimization of reproductive capacity, bone health, and acknowledgement of physical symptoms such as fatigue, hypotonic muscle strength, tremors, tics, and pain. Physical health risks associated with 47,XXY include: metabolic syndrome, Type II diabetes, cardiovascular disease, immunological issues, bone loss, and certain types of malignancies. Boys with 47,XXY frequently show executive function issues, language-based learning difficulties, problems with communication, and struggles with behavior that contribute to stressors for the boys as well as for their families. Psychosocial manifestations of these stressors include low self-esteem, increased risk for depression, difficulties maintaining personal relationships, and adverse quality of life. There is a general lack of awareness in the health care community about the complexities of care required for families who have sons with 47,XXY. Since puberty is a sentinel time for diagnosing and monitoring hypogonadism, families often depend on professionals in the specialty of endocrinology to address their many concerns. Families seeking anticipatory guidance about how 47,XXY will influence the growth and development of their sons often look to the specialty of endocrinology to help them navigate a health care environment that is confusing to them. This chapter will describe the physical, neurocognitive, and psychosocial phenotype of 47,XXY in childhood and provide suggestions for endocrine-related health surveillance for advanced practice nurses (APRN). APRNs in endocrinology practice are perfectly positioned to assess, coordinate, and provide family-centered navigation for health surveillance according to child’s level of development.
Testotoxicosis or familial male-limited precocious puberty is a rare dominant form of gonadotropin-independent precocious puberty caused by constitutively activating mutations of the luteinizing hormone receptor. Affected males present premature and progressive virilization associated with accelerated growth and advanced bone age between 2 and 4 years of age. Hormonal profile is characterized by elevated testosterone levels, despite prepubertal levels of luteinizing hormone. Treatment typically consists of reducing hyperandrogenism with ketoconazole or a combination of anti-androgens and aromatase inhibitors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- APN:
-
Advanced Practice Nurse
- BA:
-
Bone age
- c-AMP:
-
cyclic adenosine monophosphate
- cm:
-
Centimeter
- FSH:
-
Follicle stimulating hormone
- GnRH:
-
Gonadotropin releasing hormone
- G-protein:
-
Guanine-protein
- hCG:
-
Human chorionic gonadotropin
- IU/L:
-
International unit/Liter
- kg:
-
Kilogram
- KS:
-
Klinefelter syndrome
- LH:
-
Luteinizing hormone
- LHCGR:
-
Luteinizing hormone receptor gene
- mg:
-
Milligram
- ng/dL:
-
Nanogram/deciliter
- SD:
-
Standard deviation
References
Abramsky L, Chapple J. 47,XXY (Klinefelter syndrome) and 47,XYY: estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling. Prenat Diagn. 1997;17(4):363–8.
Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M. Antonini SR, et al. ong-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clin Endocrinol. 2008;69(1):93–8.
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536–59.
Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119(5):890–901.
Boada R, Janusz J, Hutaff-Lee C, Tartaglia N. The cognitive phenotype in Klinefelter syndrome: a review of the literature including genetic and hormonal factors. Dev Disabil Res Rev. 2009;15(4):284–94.
Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab. 2003;88(2):622–6.
Close S, Fennoy I, Smaldone A, Reame N. Phenotype and adverse quality of life in boys with Klinefelter syndrome. J Pediatr. 2015;167(3):650–7.
Close S, Talboy A, Fennoy I. Complexities of care in Klinefelter syndrome: an APRN perspective. Pediatr Endocrinol Rev. 2017;14(Suppl 2):462–71.
Egli CA, Rosenthal SM, Grumbach MM, Montalvo JM, Gondos B. Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. J Pediatr. 1985;106(1):33–40.
Eunice M, Philibert P, Kulshreshtha B, Audran F, Paris F, Sultan C, et al. Mother-to-son transmission of a luteinizing hormone receptor activating mutation in a prepubertal child with testotoxicosis. J Pediatr Endocrinol Metab. 2009;22(3):275–9.
Herlihy AS, Halliday JL, Cock ML, McLachlan RI. The prevalence and diagnosis rates of Klinefelter syndrome: an Australian comparison. Med J Aust. 2011;194(1):24–8.
Jacobs P, Strong J. A case of human intersexuality having a possible XXY sex-determining mechanism. Nature. 1959;183:302–3.
Jacobs PA, Hassold TJ, Whittington E, Butler G, Collyer S, Keston M, et al. Klinefelter’s syndrome: an analysis of the origin of the additional sex chromosome using molecular probes. Ann Hum Genet. 1988;52(Pt 2):93–109.
Klinefelter HF, Reifensten EC, Albright F. Syndrome characterized by gynecomastia, asermatogenesis without a-leydigism and increased secretion of follicle-stimulating hormone. J Endocrinol Metab. 1942;2:615–22.
Kremer H, Martens JW, van Reen M, Verhoef-Post M, Wit JM, Otten BJ, et al. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab. 1999;84(3):1136–40.
Lahlou N, Fennoy I, Ross JL, Bouvattier C, Roger M. Clinical and hormonal status of infants with non-mosaic XXY karyotype. Acta Paediatr. 2011;100(6):824–9.
Laue L, Chan WY, Hsueh AJ, Kudo M, Hsu SY, Wu SM, et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci U S A. 1995;92(6):1906–10.
Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med. 1999;341(23):1731–6.
Macedo DB, Silveira LF, Bessa DS, Brito VN, Latronico AC. Sexual precocity-genetic bases of central precocious puberty and autonomous gonadal activation. Endocr Dev. 2016;29:50–71.
Nieschlag E. Klinefelter syndrome: the commonest form of hypogonadism, but often overlooked or untreated. Dtsch Arztebl Int. 2013;110(20):347–53.
Paduch DA, Fine RG, Bolyakov A, Kiper J. New concepts in Klinefelter syndrome. Curr Opin Urol. 2008;18(6):621–7.
Reiter WO, Norjavaara E. Testotoxicosis: current viewpoint. Pediatr Endocrinol Rev. 2005;3(2):77–86.
Ross JL, Samango-Sprouse C, Lahlou N, Kowal K, Elder FF, Zinn A. Early androgen deficiency in infants and young boys with 47,XXY Klinefelter syndrome. Horm Res. 2005;64(1):39–45.
Ross JL, Kushner H, Kowal K, Bardsley M, Davis S, Reiss AL, et al. Androgen treatment effects on motor function, cognition, and behavior in boys with Klinefelter syndrome. J Pediatr. 2017;185:193–199.e4.
Samango-Sprouse C, Stapleton EJ, Lawson P, Mitchell F, Sadeghin T, Powell S, et al. Positive effects of early androgen therapy on the behavioral phenotype of boys with 47,XXY. Am J Med Genet C Semin Med Genet. 2015;169(2):150–7.
Schedewie HK, Reiter EO, Beitins IZ, Seyed S, Wooten VD, Jiminez JF, et al. Testicular leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab. 1981;52(2):271–8.
Styne D, Puberty GM. Ontogeny, neuroendocrinology, physiology and disorders. In: Kronenberg H, Melmed A, Polonsky K, Larsen P, editors. Williams textbook of endocrinology. Philadelphia, PA: Saunders; 2015. p. 13.
Tartaglia N, Cordeiro L, Howell S, Wilson R, Janusz J. The spectrum of the behavioral phenotype in boys and adolescents 47,XXY (Klinefelter syndrome). Pediatr Endocrinol Rev. 2010;8(Suppl 1):151–9.
Tartaglia N, Howell S, Wilson R, Janusz J, Boada R, Martin S, et al. The eXtraordinarY Kids Clinic: an interdisciplinary model of care for children and adolescents with sex chromosome aneuploidy. J Multidiscip Healthc. 2015;8:323–34.
Tartaglia NR, Wilson R, Miller JS, Rafalko J, Cordeiro L, Davis S, et al. Autism spectrum disorder in males with sex chromosome aneuploidy: XXY/Klinefelter syndrome, XYY, and XXYY. J Dev Behav Pediatr. 2017;38(3):197–207.
Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev. 2000;21(5):551–83.
van Rijn S, Stockmann L, Borghgraef M, Bruining H, van Ravenswaaij-Arts C, Govaerts L, et al. The social behavioral phenotype in boys and girls with an extra X chromosome (Klinefelter syndrome and Trisomy X): a comparison with autism spectrum disorder. J Autism Dev Disord. 2014a;44(2):310–20.
van Rijn S, Stockmann L, van Buggenhout G, van Ravenswaaij-Arts C, Swaab H. Social cognition and underlying cognitive mechanisms in children with an extra X chromosome: a comparison with autism spectrum disorder. Genes Brain Behav. 2014b;13(5):459–67.
Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab. 2004;89(12):6208–17.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Close, S., Latronico, A.C., Cunha-Silva, M. (2019). Genetic Syndromes Presenting in Childhood Affecting Gonadotropin Function. In: Llahana, S., Follin, C., Yedinak, C., Grossman, A. (eds) Advanced Practice in Endocrinology Nursing. Springer, Cham. https://doi.org/10.1007/978-3-319-99817-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-99817-6_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99815-2
Online ISBN: 978-3-319-99817-6
eBook Packages: MedicineMedicine (R0)